Organon (OGN) EBIT Margin (2020 - 2026)

Organon has reported EBIT Margin for 7 years, with the latest figure at 20.73% in Q2 2026.

• On a quarterly basis, EBIT Margin rose 41.0% year-over-year to 20.73% in Q2 2026; TTM through Jun 2026 was 18.38%, a 138.0% decrease from a year earlier, with the FY2025 full-year figure at 18.19%, down 453.0% from the prior year.
• EBIT Margin was 20.73% for Q2 2026 at Organon, up from 16.1% in the prior quarter.
• The five-year high for EBIT Margin was 34.4% in Q1 2022, with the low at 13.93% in Q4 2025.
• Average EBIT Margin over 5 years is 21.57%, with a median of 21.54% recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: EBIT Margin sank 1127 bps in 2023, then soared 938 bps in 2024.
• Over 5 years, EBIT Margin stood at 17.64% in 2022, then retreated by 14 bps to 15.14% in 2023, then increased by 19 bps to 18.09% in 2024, then fell by 23 bps to 13.93% in 2025, then surged by 49 bps to 20.73% in 2026.
• The last three EBIT Margin figures came in at 20.73% (Q2 2026), 16.1% (Q1 2026), and 13.93% (Q4 2025), per Business Quant data.